Curcumin Targets in Inflammation and Cancer

Author(s): Atsuko Deguchi

Journal Name: Endocrine, Metabolic & Immune Disorders - Drug Targets
(Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders)

Volume 15 , Issue 2 , 2015

Become EABM
Become Reviewer


Curcumin (1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) is commonly used as a spice, food additive or dietary pigment. Accumulating evidence suggests that curcumin has several pharmacologic effects, including anti-inflammatory, anti-oxidant and anti-cancer activities. The molecular mechanisms underlying the targets of curcumin are diverse and involve combinations of multiple signaling pathways, including NF-κB and STAT3 signaling. Thus, curcumin is one of the most promising phytochemicals that target various cancers and inflammation-mediated diseases. Clinical trials have been ongoing or completed for various cancers, including breast, pancreatic and colorectal cancers, and multiple myeloma. In this review, the molecular mechanisms and the issue of bioavailability are mainly discussed.

Keywords: Bioavailability, cancer, curcumin, inflammation, NF-κB, rupture.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2015
Page: [88 - 96]
Pages: 9
DOI: 10.2174/1871530315666150316120458
Price: $65

Article Metrics

PDF: 109